Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers

被引:13
作者
Im, Jae Hyoung [1 ]
Kim, Eunjung [2 ]
Lee, Eunyoung [2 ]
Seo, Yeongju [2 ]
Lee, Yuran [2 ]
Jang, Yoonkyoung [2 ]
Yu, Soyeon [2 ]
Maeng, Yeonju [2 ]
Park, Soyeon [2 ]
Park, Seohee [2 ]
Kim, Jiah [3 ]
Lee, Jin-Soo [1 ]
Baek, Ji Hyeon [1 ]
机构
[1] Inha Univ, Dept Internal Med, Div Infect Dis, Coll Med, 366 Seohaedae Ro, Incheon 22332, South Korea
[2] Inha Univ Hosp, Infect Control Unit, Incheon, South Korea
[3] Inha Univ Hosp, Dept Hlth Management, Incheon, South Korea
关键词
COVID-19; vaccine; adverse event; injection site reaction; mRNA vaccine;
D O I
10.3349/ymj.2021.62.12.1162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Pfizer-BioNTech COVID-19 vaccine has shown excellent clinical effectiveness; however, adverse events of the vaccine remain a concern in Korea. We surveyed adverse events in 2498 healthcare workers vaccinated with the Pfizer-BioNTech COVID-19 vaccine at a university hospital. The survey was conducted using a diary card for 7 days following each injection. The questionnaire response rate was 75.1% (1876/2498) for the first dose and 73.8% (1840/2493) for the second dose. Among local reactions, pain was the most commonly reported (84.9% after the first dose and 90.4% after the second dose). After the second dose, two people visited the emergency room due to severe local pain, but no hospitalization or skin necrosis occurred. Among systemic reactions, fatigue was most frequently reported (52.8% after the first dose and 77.0% after the second dose), followed by myalgia (49.0% and 76.1%), headache (28.7% and 59.2%), chills (16.7% and 54.0%), and arthralgia (11.4% and 39.2%). One or more critical adverse events occurred in 0.2% and 0.7% of the vaccinees. Except for urticaria, more adverse events were reported after the second dose than after the first dose. In the future, adverse events should be investigated in older adults, and a future study with a longer observation period should be conducted.
引用
收藏
页码:1162 / 1168
页数:7
相关论文
共 50 条
  • [41] Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals
    Nittner-Marszalska, Marita
    Rosiek-Biegus, Marta
    Kopec, Agnieszka
    Pawlowicz, Robert
    Kosinska, Magdalena
    Lata, Aleksandra
    Szenborn, Leszek
    VACCINES, 2021, 9 (06)
  • [42] Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine
    Aharoni, Maayan
    Leader, Avi
    Shochat, Tzippy
    Raanani, Pia
    Spectre, Galia
    PLATELETS, 2022, 33 (05) : 781 - 786
  • [43] Management of cardiovascular symptoms after Pfizer-BioNTech COVID-19 vaccine in teenagers in the emergency department
    Liao, Ying-Feng
    Tseng, Wei-Chieh
    Wang, Jou-Kou
    Chen, Yih-Sharng
    Chen, Chun-An
    Lin, Ming-Tai
    Lu, Chun-Wei
    Wu, Mei-Hwan
    Chiu, Shuenn-Nan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (08) : 699 - 706
  • [44] Adverse events report of inactivated COVID-19 vaccine from 4040 healthcare workers
    Tosun, Selma
    Ozdemir, Hulya Ozkan
    Erdogan, Esin
    Akcay, Seniz
    Aysin, Murat
    Eskut, Neslihan
    Ortan, Pinar
    Eskut, Burak
    POSTGRADUATE MEDICINE, 2022, 134 (01) : 104 - 110
  • [45] Bibliometric Analysis of Pfizer-BioNTech (BNT162B2): A COVID-19 Vaccine
    Hassan, Waseem
    Ara, Amina
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2021, 15 (03) : 1211 - 1229
  • [46] Strain echocardiography and cardiac MRI evaluation of a symptomatic myopericarditis after the Pfizer-BioNTech mRNA COVID-19 vaccine
    Ozdemir, Emre
    Karaca, Banu
    Altay, Sedat
    KUWAIT MEDICAL JOURNAL, 2024, 56 (04):
  • [47] Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature review
    Chahed, Ferdaous
    Ben Fadhel, Najah
    Ben Romdhane, Haifa
    Youssef, Monia
    Ben Hammouda, Seifeddine
    Chaabane, Amel
    Aouam, Karim
    Ben Fredj, Nadia
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (02) : 536 - 540
  • [48] Acute Unilateral Central Serous Chorioretinopathy after Immunization with Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Literature Review
    Raj, Palaniraj Rama
    Adler, Paul A.
    Chalasani, Rajeev
    Wan, Sue Ling
    SEMINARS IN OPHTHALMOLOGY, 2022, 37 (06) : 690 - 698
  • [49] Physiologic Response to the Pfizer-BioNTech COVID-19 Vaccine Measured Using Wearable Devices: Prospective Observational Study
    Hajduczok, Alexander G.
    DiJoseph, Kara M.
    Bent, Brinnae
    Thorp, Audrey K.
    Mullholand, Jon B.
    MacKay, Stuart A.
    Barik, Sabrina
    Coleman, Jamie J.
    Paules, Catharine, I
    Tinsley, Andrew
    JMIR FORMATIVE RESEARCH, 2021, 5 (08)
  • [50] Public health and economic impact of COVID-19 vaccination with the Pfizer-BioNTech COVID-19 Vaccine, KP.2, among adults in 2024/2025 in the United States
    Yehoshua, Alon
    Di Fusco, Manuela
    Rudolph, Abby E.
    Thoburn, Elizabeth
    Lopez, Santiago M. C.
    Marczell, Kinga
    Yarnoff, Benjamin
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1569 - 1582